Atlas Trials

Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma

Clinical trial NCT04173455 · UNKNOWN

Trial details

NCT number
NCT04173455
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma, B-Cell
Start date
2019-10-28
Primary completion
2021-09-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.